- US-listed companies
- MEDICINOVA INC
- Cash flow
MEDICINOVA INCMNOV
Market cap
$72.59M
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 2 | 2 | 100,487 | 40,186 | 26,704 | 14,127 | 28,098 | 25,881 | 23,944 | 21,342 | 26,149 | 17,707 | 20,295 | 21,077 |
| Stock-based compensation | 50 | 50 | 1 | 2 | 2 | 4 | 4 | 6 | 4 | 3 | 2 | 642,522 | 710,710 | 1 |
| Cash from operations | -13,308,652 | -11,864,438 | -10,646,456 | 816,529 | -7,152,370 | -6,546,213 | -6,923,934 | -9,114,121 | -9,124,987 | -10,826,362 | -9,381,605 | -12,911,563 | -7,431,038 | -10,642,964 |
| Capital expenditures | -2,277,590 | -2,360,968 | -41,554 | -3,523 | -2,320 | -84,483 | - | -10,200 | -11,272 | -36,492 | -28,732 | -5,010 | -21,299 | -895 |
| Cash from investing | -6,085 | -763,378 | -36,754 | -3,523 | -2,320 | -84,483 | - | 626,324 | -11,272 | -36,492 | -28,732 | -40,005,010 | 40 | -697 |
| Repurchases of common stock | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - |
| Cash from financing | 217 | 219 | 13 | 4 | 18 | 9 | 11 | 43 | 11 | 7 | 21 | 7,920 | - | - |
| Free cash flow | - | |||||||||||||
| FCF margin (%) | - | - | - | - | - | - | - | - | - |